Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Apr. 19];3:S39. Available from: https://skin.dermsquared.com/skin/article/view/766